Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Benitec Biopharma (BNTC) over the last 4 years, with Jun 2024 value amounting to $18.4 million.

  • Benitec Biopharma's Shares Outstanding (Diluted Average) rose 111.13% to $38.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $38.6 million, marking a year-over-year increase of 111.13%. This contributed to the annual value of $18.4 million for FY2024, which is 1225.17% up from last year.
  • Per Benitec Biopharma's latest filing, its Shares Outstanding (Diluted Average) stood at $18.4 million for FY2024, which was up 1,225.17% from $1.4 million recorded in FY2023.
  • In the past 5 years, Benitec Biopharma's Shares Outstanding (Diluted Average) registered a high of $18.4 million during FY2024, and its lowest value of $480,688 during FY2022.
  • In the last 3 years, Benitec Biopharma's Shares Outstanding (Diluted Average) had a median value of $1.4 million in 2023 and averaged $6.7 million.
  • Per our database at Business Quant, Benitec Biopharma's Shares Outstanding (Diluted Average) plummeted by 88.81% in 2022 and then spiked by 1,225.17% in 2024.
  • Yearly analysis of 4 years shows Benitec Biopharma's Shares Outstanding (Diluted Average) stood at $4.3 million in 2021, then slumped by 88.81% to $480,688 in 2022, then skyrocketed by 188.30% to $1.4 million in 2023, then soared by 1,225.17% to $18.4 million in 2024.